Ingredients supplier Bioiberica has revamped the brand identity for its healthcare ingredients portfolio as part of the company’s long-term growth strategy.
Ingredients supplier Bioiberica (Barcelona) has revamped the brand identity for its healthcare ingredients portfolio as part of the company’s long-term growth strategy.
Some of the company’s branded ingredients now have new names. b-2Cool, the company’s native, undenatured type II collagen for joint health, has been renamed Collavant n2. The firm’s tendon-health ingredient is called Tendaxion. Other ingredients in the portfolio include patented hyaluronic acid matrix ingredient Mobilee, as well as chondroitin sulfate ingredient CSbioactive. The company’s healthcare portfolio brand identity has also been refreshed.
“The rebrand gives customers a suite of well-defined products, made more accessible and identifiable with a clearer brand architecture,” said Jaume Reguant, Bioiberica’s director of healthcare, in a press release. He continued, “Our newly launched brand strategy for our healthcare-oriented ingredients is designed to deliver enhanced co-collaboration opportunities and a stronger foundation on which to build and market products, providing greater potential for growth in new areas—not just for Bioiberica, but our partners, too.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.